199 related articles for article (PubMed ID: 25712161)
1. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G; Richardson SL; Mao Y; Huang R
Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
[TBL] [Abstract][Full Text] [Related]
2. Kinetic mechanism of protein N-terminal methyltransferase 1.
Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
[TBL] [Abstract][Full Text] [Related]
3. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
4. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
[TBL] [Abstract][Full Text] [Related]
5. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
[TBL] [Abstract][Full Text] [Related]
6. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Noinaj N; Huang R
J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
[TBL] [Abstract][Full Text] [Related]
8. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for substrate recognition by the human N-terminal methyltransferase 1.
Dong C; Mao Y; Tempel W; Qin S; Li L; Loppnau P; Huang R; Min J
Genes Dev; 2015 Nov; 29(22):2343-8. PubMed ID: 26543161
[TBL] [Abstract][Full Text] [Related]
10. Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Deng Y; Noinaj N; Huang R
ACS Med Chem Lett; 2021 Mar; 12(3):485-493. PubMed ID: 33738076
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5.
Al-Hamashi AA; Chen D; Deng Y; Dong G; Huang R
Acta Pharm Sin B; 2021 Sep; 11(9):2709-2718. PubMed ID: 34589391
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1.
Zhou Q; Wu W; Jia K; Qi G; Sun XS; Li P
Eur J Med Chem; 2022 Dec; 244():114830. PubMed ID: 36228414
[TBL] [Abstract][Full Text] [Related]
13. Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase.
Patnaik D; Chin HG; Estève PO; Benner J; Jacobsen SE; Pradhan S
J Biol Chem; 2004 Dec; 279(51):53248-58. PubMed ID: 15485804
[TBL] [Abstract][Full Text] [Related]
14.
Jia K; Huang G; Wu W; Shrestha R; Wu B; Xiong Y; Li P
Chem Sci; 2019 Sep; 10(35):8094-8099. PubMed ID: 31857877
[TBL] [Abstract][Full Text] [Related]
15. Structure-Activity Relationship Studies of Venglustat on NTMT1 Inhibition.
Deng Y; Dong G; Meng Y; Noinaj N; Huang R
J Med Chem; 2023 Jan; 66(2):1601-1615. PubMed ID: 36634151
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).
Babault N; Allali-Hassani A; Li F; Fan J; Yue A; Ju K; Liu F; Vedadi M; Liu J; Jin J
J Med Chem; 2018 Feb; 61(4):1541-1551. PubMed ID: 29320176
[TBL] [Abstract][Full Text] [Related]
18. Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.
Iyamu ID; Vilseck JZ; Yadav R; Noinaj N; Huang R
Angew Chem Int Ed Engl; 2022 Apr; 61(16):e202114813. PubMed ID: 35134268
[TBL] [Abstract][Full Text] [Related]
19. Essential arginine residues in isoprenylcysteine protein carboxyl methyltransferase.
Boivin D; Lin W; Béliveau R
Biochem Cell Biol; 1997; 75(1):63-9. PubMed ID: 9192075
[TBL] [Abstract][Full Text] [Related]
20. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F
Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
